Departing from industry norms, Curie.Bio intentionally allocates a large equity stake to founders. They see this not just as fair but as a utilitarian strategy to gain a competitive advantage in sourcing the rarest and most valuable scientific ideas, which ultimately drives fund returns.

The government seeks VC involvement not just for capital, but for their expertise in evaluating founders and execution risk. A VC's investment is a powerful signal that helps the government allocate its own funds more efficiently to the most promising companies, essentially outsourcing talent assessment for strategic projects.

Rather than being a negative trait, a VC firm's "power"—its network and ability to influence outcomes—is a critical service for founders. Entrepreneurs have great ideas but lack access. The VC's role is to provide that power to open doors for sales, policy, and partnerships, acting as a force multiplier.

Venture capital is shifting from just funding disruptors to acquiring incumbent businesses, like a nonprofit health system. This provides a real-world environment for their portfolio startups to deploy and scale AI solutions, bypassing traditional enterprise sales cycles.

GC is shifting from a traditional venture fund to a company that incubates and holds "transformation companies" like a hospital system and an AI consultancy indefinitely. These businesses are designed for long-term value creation, not quick exits, and also serve its portfolio founders.

GC believes technology's natural gravity pulls toward concentration in a few mega-companies. Its investment thesis is to empower founders to build power-law companies that create a more distributed and inclusive innovation ecosystem, actively working against this concentration.

For its American Dynamism fund, Andreessen Horowitz provides more than capital; it fields a dedicated policy team in Washington D.C. This team works to change structural government problems, like defense procurement, creating a more favorable market for its portfolio and the broader startup ecosystem.

VC funding provides crucial leverage for securing non-dilutive grants. Many government grants operate on a reimbursement basis, requiring startups to spend capital first. Venture funding provides this necessary upfront cash, enabling hardware companies to access a powerful, complementary source of capital.

General Catalyst's Institute President states that for VCs, the founder's vision and drive are the number one consideration, even in heavily regulated sectors like healthcare. Regulatory complexity is treated as a secondary detail that a strong founder can overcome, not a primary deal-breaker.